Manning & Napier Group’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $101M | Buy |
|
|||||
|
2023
Q4 | $110M | Buy |
|
|||||
|
2023
Q3 | $101M | Buy |
|
|||||
|
2023
Q2 | $98.6M | Buy |
|
|||||
|
2023
Q1 | $107M | Buy |
|
|||||
|
2022
Q4 | $90.5M | Sell |
|
|||||
|
2022
Q3 | $79M | Sell |
|
|||||
|
2022
Q2 | $78.4M | Sell |
|
|||||
|
2022
Q1 | $131M | Sell |
|
|||||
|
2021
Q4 | $153M | Sell |
|
|||||
|
2021
Q3 | $135M | Buy |
|
|||||
|
2021
Q2 | $144M | Buy |
|
|||||
|
2021
Q1 | $129M | Buy |
|
|||||
|
2020
Q4 | $95M | Sell |
|
|||||
|
2020
Q3 | $86.2M | Buy |
|
|||||
|
2020
Q2 | $120M | Sell |
|
|||||
|
2020
Q1 | $88.8M | Sell |
|
|||||
|
2019
Q4 | $93M | Buy |
|
|||||
|
2019
Q3 | $49.2M | Buy |
|
|||||
|
2019
Q2 | $62.2M | Sell |
|
|||||
|
2019
Q1 | $80.9M | Sell |
|
|||||
|
2018
Q4 | $85.1M | Sell |
|
|||||
|
2018
Q3 | $136M | Sell |
|
|||||
|
2018
Q2 | $177M | Sell |
|
|||||
|
2018
Q1 | $155M | Sell |
|
|||||
|
2017
Q4 | $177M | Buy |
|